Compare PHAT & BBW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PHAT | BBW |
|---|---|---|
| Founded | 2018 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 942.6M | 786.9M |
| IPO Year | 2019 | 2004 |
| Metric | PHAT | BBW |
|---|---|---|
| Price | $14.45 | $53.68 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 7 |
| Target Price | $17.33 | ★ $67.71 |
| AVG Volume (30 Days) | ★ 809.7K | 509.0K |
| Earning Date | 10-30-2025 | 12-04-2025 |
| Dividend Yield | N/A | ★ 1.67% |
| EPS Growth | N/A | ★ 15.02 |
| EPS | N/A | ★ 4.36 |
| Revenue | $147,190,000.00 | ★ $525,767,000.00 |
| Revenue This Year | $218.59 | $8.36 |
| Revenue Next Year | $84.38 | $3.62 |
| P/E Ratio | ★ N/A | $12.10 |
| Revenue Growth | ★ 460.30 | 6.17 |
| 52 Week Low | $2.21 | $32.55 |
| 52 Week High | $16.45 | $75.85 |
| Indicator | PHAT | BBW |
|---|---|---|
| Relative Strength Index (RSI) | 51.19 | 53.83 |
| Support Level | $14.12 | $45.50 |
| Resistance Level | $16.45 | $55.33 |
| Average True Range (ATR) | 0.74 | 2.99 |
| MACD | -0.12 | 0.50 |
| Stochastic Oscillator | 15.88 | 68.23 |
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
Build-A-Bear Workshop Inc is a U.S.-based specialty retailer of customized stuffed animals and related products. The company operates through three segments. Its Direct-to-consumer segment with key revenue, includes the operating activities of corporately-managed locations and other retail delivery operations in the U.S., Canada, China, Denmark, Ireland, and the U.K., including the company's e-commerce sites and temporary stores. The international franchising segment includes the licensing activities of the company's franchise agreements with store locations in Europe, Asia, Australia, the Middle East, and Africa. The commercial segment includes the transactions with other businesses, mainly comprised of licensing the intellectual properties for third-party use and wholesale activities.